Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Short-Chain Fatty Acids Ameliorate Diabetic Nephropathy via GPR43-Mediated Inhibition of Oxidative Stress and NF-κB Signaling
Wei Huang, Yi Man, Chenlin Gao, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-21
Open Access | Times Cited: 143

Showing 1-25 of 143 citing articles:

Role of the gut microbiota in type 2 diabetes and related diseases
Ge Yang, Jinlong Wei, Pinyi Liu, et al.
Metabolism (2021) Vol. 117, pp. 154712-154712
Closed Access | Times Cited: 293
Short-chain fatty acids in diseases
Dan Zhang, Yong‐Ping Jian, Yuning Zhang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 211
Regulatory role of short-chain fatty acids in inflammatory bowel disease
Zhilin Zhang, Huan Zhang, Tian Chen, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 146
Butyrate ameliorates skeletal muscle atrophy in diabetic nephropathy by enhancing gut barrier function and FFA2‐mediated PI3K/Akt/mTOR signals
Gang Tang, Yi Du, Haochen Guan, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 1, pp. 159-178
Open Access | Times Cited: 136
Ginkgolide B alleviates oxidative stress and ferroptosis by inhibiting GPX4 ubiquitination to improve diabetic nephropathy
Jing Chen, Zhijie Ou, Tiantian Gao, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113953-113953
Open Access | Times Cited: 95
Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators
Manuel Grundmann, Eckhard Bender, Jens Schamberger, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1763-1763
Open Access | Times Cited: 99
Stabilized fermentation product of Cetobacterium somerae improves gut and liver health and antiviral immunity of zebrafish
Mingxu Xie, Yadong Xie, Yu Li, et al.
Fish & Shellfish Immunology (2021) Vol. 120, pp. 56-66
Open Access | Times Cited: 87
Short-chain fatty acid: An updated review on signaling, metabolism, and therapeutic effects
Kaliaperumal Rekha, Baskar Venkidasamy, Ramkumar Samynathan, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 64, Iss. 9, pp. 2461-2489
Closed Access | Times Cited: 70
Short-Chain Fatty Acids in Chronic Kidney Disease: Focus on Inflammation and Oxidative Stress Regulation
Giorgia Magliocca, Pasquale Mone, Biagio Di Iorio, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5354-5354
Open Access | Times Cited: 65
Intestinal Bacterial Translocation Contributes to Diabetic Kidney Disease
Hoang Thuy Linh, Yasunori Iwata, Yasuko Senda, et al.
Journal of the American Society of Nephrology (2022) Vol. 33, Iss. 6, pp. 1105-1119
Open Access | Times Cited: 59
Inulin-type fructans change the gut microbiota and prevent the development of diabetic nephropathy
Liman Luo, Jinlan Luo, Yueting Cai, et al.
Pharmacological Research (2022) Vol. 183, pp. 106367-106367
Closed Access | Times Cited: 56
The gut-lung axis in severe acute Pancreatitis-associated lung injury: The protection by the gut microbiota through short-chain fatty acids
Zhengjian Wang, Jin Liu, Fan Li, et al.
Pharmacological Research (2022) Vol. 182, pp. 106321-106321
Open Access | Times Cited: 54
The Specific Alteration of Gut Microbiota in Diabetic Kidney Diseases—A Systematic Review and Meta-Analysis
Yuwei Wang, Jin Zhao, Yunlong Qin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 52
Recent advances and potentiality of postbiotics in the food industry: Composition, inactivation methods, current applications in metabolic syndrome, and future trends
Yujie Zhong, Tao Wang, Ruilin Luo, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 64, Iss. 17, pp. 5768-5792
Closed Access | Times Cited: 50
Changes of gut microbiota in diabetic nephropathy and its effect on the progression of kidney injury
Kedan Cai, Yanhong Ma, Fanghao Cai, et al.
Endocrine (2022) Vol. 76, Iss. 2, pp. 294-303
Open Access | Times Cited: 44
Sodium butyrate ameliorates diabetic retinopathy in mice via the regulation of gut microbiota and related short-chain fatty acids
Yinhua Huang, Zhijie Wang, Bo Ye, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 39
Propionate exerts neuroprotective and neuroregenerative effects in the peripheral nervous system
Thomas Grüter, Nuwin Mohamad, Niklas Rilke, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 4
Open Access | Times Cited: 33
Dendrobium officinale Polysaccharide Prevents Diabetes via the Regulation of Gut Microbiota in Prediabetic Mice
Haodong Liu, Yan Xing, Yinbo Wang, et al.
Foods (2023) Vol. 12, Iss. 12, pp. 2310-2310
Open Access | Times Cited: 31
The roles of gut microbiota and its metabolites in diabetic nephropathy
Hui Zhao, Cheng-E Yang, Tian Liu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 27
Mechanisms of Qingyi Decoction in Severe Acute Pancreatitis-Associated Acute Lung Injury via Gut Microbiota: Targeting the Short-Chain Fatty Acids-Mediated AMPK/NF-κB/NLRP3 Pathway
Zhengjian Wang, Jin Liu, Fan Li, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 24
Fucoidan Improves Early Stage Diabetic Nephropathy via the Gut Microbiota–Mitochondria Axis in High-Fat Diet-Induced Diabetic Mice
Zhaoyi Zhong, Yangting Zhang, Wei Yuan, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 17, pp. 9755-9767
Closed Access | Times Cited: 9
Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota
Xiaqing Wu, Lei Zhao, Yanlong Zhao, et al.
Pharmaceutical Biology (2024) Vol. 62, Iss. 1, pp. 423-435
Open Access | Times Cited: 9
Gut dysbiosis in primary sarcopenia: potential mechanisms and implications for novel microbiome-based therapeutic strategies
Wei Yang, Si-Cong Si, Weihua Wang, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access | Times Cited: 1
Roles of Gut Microbial Metabolites in Diabetic Kidney Disease
Qing Fang, Na Liu, Binjie Zheng, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 48
Chicoric Acid Attenuated Renal Tubular Injury in HFD-Induced Chronic Kidney Disease Mice through the Promotion of Mitophagy via the Nrf2/PINK/Parkin Pathway
Xiaoqin Ding, Tunyu Jian, Yanan Gai, et al.
Journal of Agricultural and Food Chemistry (2022) Vol. 70, Iss. 9, pp. 2923-2935
Closed Access | Times Cited: 37
Page 1 - Next Page

Scroll to top